Review
doi: 10.1016/j.blre.2003.12.001.
Dendritic cells in vaccination therapies of human malignant disease
Affiliations
- PMID: 15501552
- DOI: 10.1016/j.blre.2003.12.001
Item in Clipboard
Review
Dendritic cells in vaccination therapies of human malignant disease
Blood Rev.
2004 Dec.
Abstract
Dendritic cells (DC) are the most efficient antigen presenting cells in various in vitro systems and DC are now introduced to early clinical use. Tumor antigen loaded DC might potentially add therapeutic benefit with dendritic cell based vaccination. This review will focus on dendritic cell biology relevant to investigators who work in transitional research programs and will discuss the rationale of DC source, antigen loading and route of vaccination. An overview of published and on-going clinical trials in human malignant diseases will be provided forming the basis for a discussion of perspectives of dendritic cell vaccination in various human malignancies.
Similar articles
-
Dendritic cell vaccination for cancer therapy.Oncogene. 2000 Dec 27;19(56):6673-9. doi: 10.1038/sj.onc.1204095. Oncogene. 2000. PMID: 11426654 Review.
-
DC-based immunotherapy of B-cell malignancies.Cytotherapy. 2004;6(1):62-7. doi: 10.1080/14653240310004584. Cytotherapy. 2004. PMID: 14985168 Review.
-
Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.Handb Exp Pharmacol. 2009;(188):319-48. doi: 10.1007/978-3-540-71029-5_15. Handb Exp Pharmacol. 2009. PMID: 19031033 Review.
-
Dendritic cell-based immunotherapy of malignant melanoma: success and limitations.J Dtsch Dermatol Ges. 2007 Mar;5(3):190-6. doi: 10.1111/j.1610-0387.2007.06179.x. J Dtsch Dermatol Ges. 2007. PMID: 17338793 Review. English, German.
-
Immunotherapy with dendritic cells for cancer.Adv Drug Deliv Rev. 2008 Jan 14;60(2):173-83. doi: 10.1016/j.addr.2007.08.026. Epub 2007 Oct 5. Adv Drug Deliv Rev. 2008. PMID: 17977615 Review.
Cited by
-
Maturation and upregulation of functions of murine dendritic cells (DCs) under the influence of purified aromatic-turmerone (AR).Hum Vaccin Immunother. 2012 Oct;8(10):1416-24. doi: 10.4161/hv.21526. Epub 2012 Oct 1. Hum Vaccin Immunother. 2012. PMID: 23095866 Free PMC article.
-
Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials.Part Fibre Toxicol. 2019 Apr 11;16(1):18. doi: 10.1186/s12989-019-0299-z. Part Fibre Toxicol. 2019. PMID: 30975174 Free PMC article. Review.
-
Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives.Bone Marrow Transplant. 2016 Feb;51(2):163-71. doi: 10.1038/bmt.2015.256. Epub 2015 Oct 26. Bone Marrow Transplant. 2016. PMID: 26501766 Review.
-
Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading.J Immune Based Ther Vaccines. 2005 Jul 19;3:4. doi: 10.1186/1476-8518-3-4. J Immune Based Ther Vaccines. 2005. PMID: 16029505 Free PMC article.
-
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.J Clin Med. 2020 Sep 14;9(9):2967. doi: 10.3390/jcm9092967. J Clin Med. 2020. PMID: 32937961 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
